Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MoonLake Immunotherapeutics - Class A Ordinary Shares
(NQ:
MLTX
)
12.52
-0.73 (-5.51%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,952,384
Open
13.12
Bid (Size)
12.60 (100)
Ask (Size)
12.68 (500)
Prev. Close
13.25
Today's Range
12.48 - 13.22
52wk Range
5.950 - 62.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines
December 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
December 01, 2025
From
Schall Law
Via
GlobeNewswire
Performance
YTD
-76.6%
-76.6%
1 Month
+22.7%
+22.7%
3 Month
-78.6%
-78.6%
6 Month
-74.2%
-74.2%
1 Year
-77.4%
-77.4%
More News
Read More
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)
December 01, 2025
From
Bernstein Liebhard LLP
Via
GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
November 29, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash
↗
November 28, 2025
Via
The Motley Fool
Topics
Lawsuit
Regulatory Compliance
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That MoonLake Immunotherapeutics Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 28, 2025
Via
NewMediaWire
Topics
Lawsuit
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That MoonLake Immunotherapeutics Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 28, 2025
Via
TheNewswire.com
Topics
Lawsuit
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash
↗
November 27, 2025
Via
The Motley Fool
Topics
Lawsuit
Regulatory Compliance
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
November 27, 2025
From
Schall Law
Via
GlobeNewswire
MLTX Class Action Reminder – Robbins LLP Reminds MoonLake Immunotherapeutics Stockholders of the Opportunity to Lead the Class Action Lawsuit
November 25, 2025
From
Robbins LLP
Via
GlobeNewswire
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
November 25, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
November 25, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines
November 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
November 24, 2025
From
Schall Law
Via
GlobeNewswire
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & Korsinsky
November 24, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & Korsinsky
November 24, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)
November 24, 2025
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
November 22, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX
November 21, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX
November 21, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
November 20, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
November 20, 2025
From
Schall Law
Via
GlobeNewswire
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
November 20, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
November 20, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
November 19, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Frequently Asked Questions
Is MoonLake Immunotherapeutics - Class A Ordinary Shares publicly traded?
Yes, MoonLake Immunotherapeutics - Class A Ordinary Shares is publicly traded.
What exchange does MoonLake Immunotherapeutics - Class A Ordinary Shares trade on?
MoonLake Immunotherapeutics - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MoonLake Immunotherapeutics - Class A Ordinary Shares?
The ticker symbol for MoonLake Immunotherapeutics - Class A Ordinary Shares is MLTX on the Nasdaq Stock Market
What is the current price of MoonLake Immunotherapeutics - Class A Ordinary Shares?
The current price of MoonLake Immunotherapeutics - Class A Ordinary Shares is 12.52
When was MoonLake Immunotherapeutics - Class A Ordinary Shares last traded?
The last trade of MoonLake Immunotherapeutics - Class A Ordinary Shares was at 12/02/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.